European Patent approval for new injectable drug delivery technology

European Patent approval for new injectable drug delivery technology

2018-03-27T14:45:56+00:00 August 8th, 2012|

“The continuously growing portfolio will help our customers to protect even better their investments in our co-operation projects.”

Mika Jokinen, Director R&D: this new patent approval is an example of the continuous work aiming at strengthening DelSiTech´s patent portfolio in the field of silica based drug delivery technology. The continuously growing portfolio will help our customers to protect even better their investments in our co-operation projects.